Selectis Health, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $41.4M | $39.5M | $36.8M | $40.6M | $29.3M | $20.9M | $6.9M | $3.6M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $8.9M | $9.2M | $10.0M | $7.9M | $5.9M | $2.1M | $1.3M | $1.2M |
| Operating Income | $-1.6M | $-2.7M | $-9.0M | $-286.6K | $-729.0K | $3.4M | $1.3M | $340.0K |
| Operating Margin | -3.8% | -6.9% | -24.4% | -0.7% | -2.5% | 16.1% | 18.8% | 9.4% |
| Interest Expense | — | — | $2.2M | $2.2M | $2.5M | $2.1M | $2.1M | $2.1M |
| Pretax Income | $-1.0M | $-2.4M | — | — | — | — | — | — |
| Income Tax Expense | $800 | — | — | — | — | — | — | — |
| Net Income | $-1.0M | $-2.4M | $-4.0M | $-2.4M | $-2.3M | $3.0M | $-861.6K | $-2.0M |
| Net Margin | -2.5% | -6.1% | -10.8% | -5.9% | -7.7% | 14.1% | -12.4% | -55.0% |
| EPS (Basic) | $-0.34 | $-0.80 | $-1.31 | $-0.79 | $-0.82 | $1.07 | $-0.03 | $-0.08 |
| EPS (Diluted) | $-0.34 | $-0.80 | $-1.31 | $-0.79 | $-0.82 | $0.95 | $-0.03 | $-0.08 |
| Shares Outstanding (Basic) | 3.1M | 3.1M | 3.1M | 3.1M | 2.8M | 2.7M | 27.3M | 26.9M |
| Shares Outstanding (Diluted) | 3.1M | 3.1M | 3.1M | 3.1M | 2.8M | 3.1M | 27.3M | 26.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |